SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 203.54+2.2%12:33 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (11967)12/2/1997 10:25:00 AM
From: Hippieslayer  Read Replies (1) of 32384
 
Henry,

The letter was dated Nov 18th. The expantion will be done in Europe and in Australia.

Also attached are the cities where the trials are taking place

Here are the international cities:
edmonton, montreal, toronto, Vancouver,
France:chambray-les-tours
Clermont-ferrand
creteil,nantes,reims,rouen
Poland:Gdansk,Lublin,Lodz,Poznan,Warsaw,Wroclaw
Spain:Barcelona, Madrid
Australia:Melbourne

I wonder why no trials in Asia? I would think that there would be a decent amount of cases located in the region.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News